The global pandemic of COVID-19 is continuing to have a significant effect on the well-being of global population, increasing the demand for rapid testing, diagnosis, and treatment. Along with COVID-19, other etiologies of pneumonia and tuberculosis constitute additional challenges to the medical system. In this regard, the objective of this work is to develop a new deep transfer learning pipeline to diagnose patients with COVID-19, pneumonia, and tuberculosis, based on chest x-ray images. We observed in some instances DenseNet and Resnet have orthogonal performances. In our proposed model, we have created an extra layer with convolutional neural network blocks to combine these two models to establish superior performance over either model. The same strategy can be useful in other applications where two competing networks with complementary performance are observed. We have tested the performance of our proposed network on two-class (pneumonia vs healthy), three-class (including COVID-19), and four-class (including tuberculosis) classification problems. The proposed network has been able to successfully classify these lung diseases in all four datasets and has provided significant improvement over the benchmark networks of DenseNet, ResNet, and Inception-V3. These novel findings can deliver a state-of-the-art pre-screening fast-track decision network to detect COVID-19 and other lung pathologies.
翻译:COVID-19这一全球流行病继续对全球人口的福祉产生重大影响,增加了对快速检测、诊断和治疗的需求。与COVID-19一样,肺炎和肺结核的其他病原体对医疗系统构成额外的挑战。在这方面,这项工作的目标是开发一个新的深传输学习管道,根据胸前X射线图像诊断COVID-19、肺炎和肺结核患者。我们观察到,有时DenseNet和Resnet有骨质性能。在我们拟议的模型中,我们创建了具有进化神经网络块的额外层,将这两种模型结合起来,以建立优于两种模型的功能。在其他应用中,观察到两个相互竞争的网络相辅相成,也是有用的。我们已经在两种级别(肺炎与健康),三级(包括COVID-19)和四级(包括肺结核)分类问题上测试了我们的拟议网络的绩效。拟议网络成功地将这些肺病分解在所有四个数据集中,并大大改进了这两种模型,从而建立了优于这两种模型的优于两种模型。在两种应用中都观察到了互补性功能的网络。我们用两种相互竞争的网络在两种应用中测试了我们所拟议的网络的业绩。我们用两种(包括CVID-Ception-Ception-Ception-Ception-Ception-Cast-Cath-Cast-Cast-Creal-Cast-Cy-Creal)网络和Cheption-Cheption-Chy-Cheption-Chy-Chy-Chy-stal-stal-C-Chy-Chy-Chy-Chymal-Chy-hy-hy-hy-hy-hy-hy-hy-hy-hy-hy-hy-hy-hy-C3。